Positron Emission Tomography in Dementia
Seiten
1990
John Wiley & Sons Inc (Verlag)
978-0-471-56804-9 (ISBN)
John Wiley & Sons Inc (Verlag)
978-0-471-56804-9 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Examines current data obtained with positron emission tomography (PET) on patients with demands of the Alzheimer type (DAT) and related neurological disorders. The influence on the measurement of brain atrophy and activation state is examined in detail, as are specific aspects of the PET procedure.
The major contribution of Positron Emission Tomography (PET) has been to bring into the clinical arena many aspects of neurophysiology and pharmacology that were previously considered to be solely the domain of basic laboratory research. The applications of PET have forced the clinician to consider regional brain physiology not as an abstract concept but as a quantifiable reality. This achievement symbolizes the transition of the traditional view of neurological diseases as distortions of structure, to one of physiological or functional alterations from normality. This transition is particularly important for an understanding of the mechanisms by which diseases of the brain cause dementia. This volume explores current data, obtained with PET, on patients with demands of the Alzheimer type (DAT) and related neurological disorders. The influences on measurements of brain atrophy and the activation state are examined in detail, as are specific aspects of the PET procedure.
The major contribution of Positron Emission Tomography (PET) has been to bring into the clinical arena many aspects of neurophysiology and pharmacology that were previously considered to be solely the domain of basic laboratory research. The applications of PET have forced the clinician to consider regional brain physiology not as an abstract concept but as a quantifiable reality. This achievement symbolizes the transition of the traditional view of neurological diseases as distortions of structure, to one of physiological or functional alterations from normality. This transition is particularly important for an understanding of the mechanisms by which diseases of the brain cause dementia. This volume explores current data, obtained with PET, on patients with demands of the Alzheimer type (DAT) and related neurological disorders. The influences on measurements of brain atrophy and the activation state are examined in detail, as are specific aspects of the PET procedure.
Utilization of Positron Emission Tomography for Research and Clinical Applications in Dementia; Quantification and Analysis of Positron Emission Tomography Metabolic Data; Effect of Cerebral Atrophy in Positron Emission Tomography Studies of Aging and Dementia; Resting State Regional Cerebral Metabolism in Dementia of the Alzheimer Type; Positron Emission Tomography and Huntington's Disease; Utilization of Behavioural Activation Paradigms for Positron Emission Tomography Studies in Normal Young and Elderly Subjects and in Dementia; Potential Application of Radiolabeled Ligand Studies of Dementing Disease by Positron Emission Tomography; Positron and Single Photon Emission Tomography in the Differential Diagnosis of Dementia.
| Reihe/Serie | Frontiers of clinical neuroscience ; vol 10 |
|---|---|
| Zusatzinfo | Ill. |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 61 x 80 mm |
| Gewicht | 737 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie |
| Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Computertomographie | |
| ISBN-10 | 0-471-56804-X / 047156804X |
| ISBN-13 | 978-0-471-56804-9 / 9780471568049 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Orthopädie, Traumatologie, Rheumatologie, Onkologie
Buch | Hardcover (2017)
Urban & Fischer in Elsevier (Verlag)
CHF 208,55
